Novartis AG
METHODS FOR TREATING MEIBOMIAN GLAND DYSFUNCTION WITH LIVER X RECEPTOR AGONISTS
Last updated:
Abstract:
The present invention provides methods for treating meibomian gland dysfunction using liver X receptor (LXR) agonists.
Status:
Application
Type:
Utility
Filling date:
13 Jul 2020
Issue date:
18 Aug 2022